DD

Divyesh Dineshbhai Patel

Active Director Director DIN 08813967
DIN 08813967 First appointment Jul 2020 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Divyesh Dineshbhai Patel

Data last updated:

Divyesh Dineshbhai Patel is a Director at Orient Pharmachem Private Limited (since 2020). The company operates in Chemicals and Materials.

DIN 08813967
Primary Designation Director
Industry Chemicals and Materials
First Appointment 29 Jul 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Orient Pharmachem Private Limited U24299GJ2020PTC115107
Director29 Jul 20202020Active

Board colleagues of Divyesh Dineshbhai Patel

Directorship timeline

Open interactive timeline →
Orient Pharmachem Private Limited
Premium access

Shareholding and investment profile for Divyesh Dineshbhai Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Divyesh Dineshbhai Patel

Divyesh Dineshbhai Patel currently holds 1 directorship: Orient Pharmachem Private Limited (Director, since 29 Jul 2020).

Divyesh Dineshbhai Patel was first appointed on 29 Jul 2020 as Director at Orient Pharmachem Private Limited.

The current boards of Divyesh Dineshbhai Patel's companies include Dineshbhai Madhavlal Patel (Orient Pharmachem Private Limited), Tejas Dineshbhai Patel (Orient Pharmachem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available